Mankind Pharma management to attend IIFL conference in London

Mankind Pharma management will attend IIFL's Invest India Conference and Capital Day 2026 in London on June 23 and June 24, 2026. The participation includes one-on-one and group meetings with investors. The company stated that no unpublished price sensitive information will be shared during the conference. The schedule is subject to change due to exigencies on either side.

Participation Details

The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer.

Date	Name of Event	City	Meeting Type
June 23, 2026 & June 24, 2026	IIFL's Invest India Conference & Capital Day 2026	London	One on One and Group Meeting

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.34%	-1.13%	-5.55%	+12.26%	-0.25%	+66.22%

Mankind Pharma promoters and promoter group have confirmed that no encumbrance was made on the shares held by them during the financial year ended March 31, 2026. The disclosure was submitted to the stock exchanges pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The confirmation is intended to inform shareholders and regulatory bodies about the status of the promoters' holdings.

The filing, dated April 07, 2026, was signed by Ramesh Juneja, Promoter of Mankind Pharma Limited. It explicitly states that neither the promoters nor the promoter group, along with persons acting in concert, have created any direct or indirect encumbrance on their shareholdings in the company during FY26. This compliance ensures transparency regarding the leverage or pledging of promoter shares, a key metric for investor risk assessment.

The disclosure includes a comprehensive list of 89 entities categorized as promoters, promoter group, and persons acting in concert. The list details the specific individuals, family trusts, and corporate entities that fall under these classifications.

List of Promoters

S. No.	Name	Category
1.	Ramesh Juneja	Promoter
2.	Rajeev Juneja	Promoter
3.	Sheetal Arora	Promoter
4.	Ramesh Juneja Family Trust	Promoter
5.	Rajeev Juneja Family Trust	Promoter
6.	Prem Sheetal Family Trust	Promoter

Promoter Group Entities

The promoter group comprises 83 additional entities, including family members, HUFs, and various private limited companies and LLPs. Notable entities within the promoter group include Poonam Juneja, Arjun Juneja, and corporate entities such as Mankind Biotech Private Limited, Pathkind Diagnostics Private Limited, and Bestochem Formulations (India) Limited. The full list of 89 entities is attached as Annexure-1 to the regulatory filing.